Acta Anatomica Sinica ›› 2018, Vol. 49 ›› Issue (1): 127-131.doi: 10.16098/j.issn.0529-1356.2018.01.022
• Review • Previous Articles Next Articles
LIN Bo1 PAN Wei-tong2 KONG Jing3 Lü Xin-rui 3*
Received:
2017-05-15
Revised:
2017-09-11
Online:
2017-02-06
Published:
2018-02-06
Contact:
Lü Xin-rui
E-mail:lvxinrui@126.com
LIN Bo PAN Wei-tong KONG Jing Lü Xin-rui. Function of apelin/APJ signal in liver cirrhosis and hepatocellular carcinoma[J]. Acta Anatomica Sinica, 2018, 49(1): 127-131.
[1]O’Dowd BF, Heiber M, Chan A, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11 [J]. Gene, 1993, 136(1-2): 355-360.
[2]Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor [J]. Biochem Biophys Res Commun, 1998, 251(2): 471-476.
[3]He L, Xu J, Chen L, et al. Apelin/APJ signaling in hypoxia-related diseases [J]. Clin Chim Acta, 2015, 451(Pt B): 191-198.
[4]Chaves-Almagro C, Castan-Laurell I, Dray C, et al. Apelin receptors: From signaling to antidiabetic strategy [J]. Eur J Pharmacol, 2015, 763(Pt B): 149-159.
[5]Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine [J]. Pharmacol Ther, 2005, 107(2): 198-211.
[6]Lee DK, Cheng R, Nguyen T, et al. Characterization of apelin, the ligand for the APJ receptor [J]. J Neurochem, 2000, 74(1): 34-41.
[7]Medhurst AD, Jennings CA, Robbins MJ, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin [J]. J Neurochem, 2003, 84(5): 1162-1172.
[8]Yokomori H, Oda M, Yoshimura K, et al. Enhanced expressions of apelin on proliferative hepatic arterial capillaries in human cirrhotic liver [J]. Hepatol Res, 2012, 42(5): 508-514.
[9]Lim YL, Choi E, Jang YO, et al. Clinical implications of the serum apelin level on portal hypertension and prognosis of liver cirrhosis [J]. Gut Liver, 2016, 10(1): 109-116.
[10]Lin ZY, Chuang WL. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts [J]. Kaohsiung J Med Sci, 2013, 29(6): 312-318.
[11]Yoshiya S, Shirabe K, Imai D, et al. Blockade of the apelin-APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy [J]. J Gastroenterol, 2015, 50(5): 573-582.
[12]Ishida J, Hashimoto T, Hashimoto Y, et al. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo [J]. J Biol Chem, 2004, 279(25): 26274-26279.
[13]Szokodi I, Tavi P, Foldes G, et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility [J]. Circ Res, 2002, 91(5): 434-440.
[14]Cox CM, D’Agostino SL, Miller MK, et al. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo [J]. Dev Biol, 2006, 296(1): 177-189.
[15]Chun HJ, Ali ZA, Kojima Y, et al. Apelin signaling antagonizes Ang Ⅱ effects in mouse models of atherosclerosis [J]. J Clin Invest, 2008, 118(10): 3343-3354.
[16]O’Donnell LA, Agrawal A, Sabnekar P, et al. Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury [J]. J Neurochem, 2007, 102(6): 1905-1917.
[17]Cook DR, Gleichman AJ, Cross SA, et al. NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury [J]. J Neurochem, 2011, 118(6): 1113-1123.
[18]Khaksari M, Aboutaleb N, Nasirinezhad F, et al. Apelin-13 protects the brain against ischemic reperfusion injury and cerebral edema in a transient model of focal cerebral ischemia [J]. J Mol Neurosci, 2012, 48(1): 201-208.
[19]Cayabyab M, Hinuma S, Farzan M, et al. Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry [J]. J Virol, 2000, 74(24): 11972-11976.
[20]Kidoya H, Kunii N, Naito H, et al. The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy [J]. Oncogene, 2011, 31(27): 3254-3264.
[21]Wang G, Anini Y, Wei W, et al. Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion [J]. Endocrinology, 2004, 145(3): 1342-1348.
[22]Wattez JS, Ravallec R, Cudennec B, et al. Apelin stimulates both cholecystokinin and glucagon-like peptide 1 secretions in vitro and in vivo in rodents [J]. Peptides, 2013, 48(5): 134-136.
[23]Sorhede Winzell M, Magnusson C, Ahren B. The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice [J]. Regul Pept, 2005, 131(1): 12-17.
[24]Shin K, Chapman NA, Sarker M, et al. Bioactivity of the putative apelin proprotein expands therepertoire of apelin receptor ligands [J]. Biochim Biophys Acta, 2017,1861(8):1901-1912.
[25]Rak A, Drwal E, Rame C, et al. Knapczyk-Stwora KExpression of apelin and apelin receptor (APJ) in porcine ovarian follicles and in vitro effect of apelin on steroidogenesis and proliferation through APJ activation and different signaling pathways [J].Theriogenology, 2017,96:126-135.
[26] Yuan ZS, Zhou YZ, Liao XB, et al. Apelin attenuates the osteoblastic differentiation of aortic valve interstitial cells via the ERK and PI3-K/Akt pathways [J]. Amino Acids, 2015, 47 (12):2475-2482.
[27]Daviaud D, Boucher J, Gesta S, et al. TNF alpha up-regulates apelin expression in human and mouse adipose tissue [J]. FASEB J, 2006, 20 (9):1528-1530.
[28]Melgar-Lesmes P, Casals G, Pauta M, et al. Apelin mediates the induction of profibrogenic genes in human hepatic stellate cells [J]. Endocrinology, 2010, 151(11): 5306-5314.
[29]RonkainenV, RonkainenJ, Hanninen L, et al. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin [J]. FASEB J, 2007, 21 (8):1821-1830.
[30]Lv XR, Zheng B, Li SY, et al. Synthetic retinoid Am80 upregulates apelin expression by promoting interaction of RARα with KLF5 and Sp1 in vascular smooth muscle cells [J]. Biochem J,2013, 456 (2): 35-46.
[31]Chu J, Zhang H, Huang X, et al. Apelin ameliorates TNF-alpha-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ [J]. PLoS One, 2013, 8(2): e57231.
[32]Jeong K, Oh Y, Kim SJ, et al. Apelin is transcriptionally regulated by ER stress-induced ATF4 expression via a p38 MAPK-dependent pathway [J]. Apoptosis, 2014, 19(9): 1399-1410.
[33]Melgar-Lesmes P, Pauta M, Reichenbach V, et al. Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes [J]. Gut, 2011, 60(10): 1404-1411.
[34]Principe A, Melgar-Lesmes P, Fernandez-Varo G, et al. The hepatic apelin system: a new therapeutic target for liver disease [J]. Hepatology, 2009, 49(3): 1193-1201.
[35]Drougard A, Duparc T, Brenachot X, et al. Hypothalamic apelin/reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes [J]. Antioxid Redox Signal, 2014, 20(4): 557-573.
[36]Kalafateli M, Triantos C, Tsochatzis E, et al. Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis [J]. World J Gastroenterol, 2015, 21(10): 3020-3029.
[37]Yokomori H, Oda M, Yoshimura K, et al. Overexpression of apelin receptor (APJ/AGTRL1) on hepatic stellate cells and sinusoidal angiogenesis in human cirrhotic liver [J]. J Gastroenterol, 2011, 46(2): 222-231.
[38]Chen W, Oue T, Ueno T, et al. Apelin is a marker of the progression of liver fibrosis and portal hypertension in patients with biliary atresia [J]. Pediatr Surg Int, 2013, 29(1): 79-85.
[39]Lv D, Li L, Lu Q, et al. PAK1-cofilin phosphorylation mediates human lung adenocarcinoma cells migration induced by apelin-13 [J]. Clin Exp Pharmacol Physiol, 2016, 43(5): 569-579.
[40]Picault FX, Chaves-Almagro C, Projetti F, et al. Tumour co-expression of apelin and its receptor is the basis of an autocrine loop involved in the growth of colon adenocarcinomas [J]. Eur J Cancer, 2014, 50(3): 663-674.
[41]Altinkaya SO, Nergiz S, Kucuk M, et al. Apelin levels are higher in obese patients with endometrial cancer [J]. J Obstet Gynaecol Res, 2015, 41(2): 294-300.
[42]Wan Y, Zeng ZC, Xi M, et al. Dysregulated microRNA-224/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancer [J]. Hum Pathol, 2015, 46(2): 295-303.
[43]Farid RM, Abu-Zeid RM, El-Tawil A. Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients [J]. Int J Clin Exp Pathol, 2014, 7(5): 2707-2717.
[44]Liu Q, Hu T, He L, et al. Genetic targeting of sprouting angiogenesis using Apln-CreER [J]. Nat Commun, 2015, 6: 6020.
[45]Takakura N, Kidoya H. Maturation of blood vessels by haematopoietic stem cells and progenitor cells: involvement of apelin/APJ and angiopoietin/Tie2 interactions in vessel caliber size regulation [J]. Thromb Haemost, 2009, 101(6): 999-1005.
[46]Sorli SC, Le Gonidec S, Knibiehler B, et al. Apelin is a potent activator of tumour neoangiogenesis [J]. Oncogene, 2007, 26(55): 7692-7699.
[47]Muto J, Shirabe K, Yoshizumi T, et al. The apelin-APJ system induces tumor arteriogenesis in hepatocellular carcinoma [J]. Anticancer Res, 2014, 34(10): 5313-5320.
[48]Esposito V, De Falco M, De Luca L, et al. Immunohistochemical study of apelin, the natural ligand of receptor APJ, in a case of AIDS-related cachexia [J]. In Vivo, 2002, 16(5): 337-340.
[49]Zou MX, Liu HY, Haraguchi Y, et al. Apelin peptides block the entry of human immunodeficiency virus (HIV) [J]. Febs Letters, 2000, 473(1): 15-18.
[50]Horiuchi Y, Fujii T, Kamimura Y, et al. The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity during immunological responses [J]. J Neuroimmunol, 2003, 144(1-2): 46-52.
[51]Papangeli I, Kim J, Maier I, et al.MicroRNA 139-5p coordinates APLNR-CXCR4 crosstalk during vascular maturation [J]. Nat Commun, 2016,7:11268.
[52]Zang XY,Geng XF,Zhang ChY, et al. Role of microRNAs in liver regeneration [J]. Acta Anatomica Sinica, 2017, 48 (2):230-235. (in Chinese)
臧夏炎,耿小芳,张春艳,等. MicroRNA在肝再生中的作用研究进展[J]. 解剖学报, 2017,48(2):230-235.
|
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||